vs
Side-by-side financial comparison of Marygold Companies, Inc. (MGLD) and TriSalus Life Sciences, Inc. (TLSI). Click either name above to swap in a different company.
TriSalus Life Sciences, Inc. is the larger business by last-quarter revenue ($13.2M vs $7.6M, roughly 1.7× Marygold Companies, Inc.). Marygold Companies, Inc. runs the higher net margin — -7.5% vs -73.9%, a 66.3% gap on every dollar of revenue. On growth, TriSalus Life Sciences, Inc. posted the faster year-over-year revenue change (59.8% vs -4.5%). Over the past eight quarters, TriSalus Life Sciences, Inc.'s revenue compounded faster (43.0% CAGR vs -1.5%).
Marygold Companies, Inc. is a U.S.-headquartered diversified holding company that operates across three core segments: financial services, specialty manufacturing, and consumer goods. It primarily caters to North American markets, driving long-term value growth via strategic investment in, and operational optimization of, its portfolio of subsidiary entities.
TriSalus Life Sciences, Inc. is a clinical-stage biotechnology company focused on advancing immuno-oncology and interventional oncology solutions. It develops proprietary targeted drug delivery technologies designed to improve treatment efficacy for patients with liver, pancreatic and other hard-to-treat solid tumors, primarily operating in North American markets via partnerships with clinical care and research institutions.
MGLD vs TLSI — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $7.6M | $13.2M |
| Net Profit | $-576.0K | $-9.8M |
| Gross Margin | 74.0% | 86.7% |
| Operating Margin | -8.3% | -24.8% |
| Net Margin | -7.5% | -73.9% |
| Revenue YoY | -4.5% | 59.8% |
| Net Profit YoY | 67.0% | 3.5% |
| EPS (diluted) | $-0.01 | $-0.22 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $7.6M | $13.2M | ||
| Q3 25 | $7.0M | $11.6M | ||
| Q2 25 | $7.2M | $11.2M | ||
| Q1 25 | $7.0M | $9.2M | ||
| Q4 24 | $8.0M | $8.3M | ||
| Q3 24 | $7.9M | $7.3M | ||
| Q2 24 | $8.3M | $7.4M | ||
| Q1 24 | $7.9M | $6.5M |
| Q4 25 | $-576.0K | $-9.8M | ||
| Q3 25 | $-356.0K | $-10.8M | ||
| Q2 25 | $-1.5M | $-8.3M | ||
| Q1 25 | $-1.0M | $-10.4M | ||
| Q4 24 | $-1.7M | $-10.1M | ||
| Q3 24 | $-1.6M | $-2.4M | ||
| Q2 24 | $-1.9M | $-4.3M | ||
| Q1 24 | $-529.0K | $-13.2M |
| Q4 25 | 74.0% | 86.7% | ||
| Q3 25 | 77.0% | 83.5% | ||
| Q2 25 | 67.8% | 83.9% | ||
| Q1 25 | 75.0% | 83.7% | ||
| Q4 24 | 74.1% | 85.3% | ||
| Q3 24 | 73.1% | 86.3% | ||
| Q2 24 | 72.5% | 87.6% | ||
| Q1 24 | 70.5% | 85.0% |
| Q4 25 | -8.3% | -24.8% | ||
| Q3 25 | -18.2% | -77.9% | ||
| Q2 25 | -16.5% | -65.4% | ||
| Q1 25 | -21.4% | -79.9% | ||
| Q4 24 | -22.8% | -91.8% | ||
| Q3 24 | -27.4% | -118.9% | ||
| Q2 24 | -33.3% | -111.0% | ||
| Q1 24 | -18.7% | -180.8% |
| Q4 25 | -7.5% | -73.9% | ||
| Q3 25 | -5.1% | -93.5% | ||
| Q2 25 | -20.4% | -73.9% | ||
| Q1 25 | -14.4% | -113.2% | ||
| Q4 24 | -21.8% | -122.4% | ||
| Q3 24 | -20.1% | -32.6% | ||
| Q2 24 | -22.5% | -58.8% | ||
| Q1 24 | -6.7% | -204.5% |
| Q4 25 | $-0.01 | $-0.22 | ||
| Q3 25 | $-0.01 | $-0.96 | ||
| Q2 25 | $-0.04 | $-0.27 | ||
| Q1 25 | $-0.02 | $-0.39 | ||
| Q4 24 | $-0.04 | $-0.38 | ||
| Q3 24 | $-0.04 | $-0.12 | ||
| Q2 24 | $-0.05 | $-0.21 | ||
| Q1 24 | $-0.01 | $-0.60 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $11.6M | $20.4M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $22.7M | $-33.9M |
| Total Assets | $27.8M | $35.3M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $11.6M | $20.4M | ||
| Q3 25 | $12.5M | $22.7M | ||
| Q2 25 | $12.8M | $26.5M | ||
| Q1 25 | $15.6M | $13.0M | ||
| Q4 24 | $14.9M | $8.5M | ||
| Q3 24 | $17.5M | $11.3M | ||
| Q2 24 | $15.0M | $16.5M | ||
| Q1 24 | $16.1M | $4.0M |
| Q4 25 | $22.7M | $-33.9M | ||
| Q3 25 | $22.9M | $-26.7M | ||
| Q2 25 | $23.0M | $-19.4M | ||
| Q1 25 | $24.3M | $-34.4M | ||
| Q4 24 | $23.4M | $-25.9M | ||
| Q3 24 | $25.5M | $-20.4M | ||
| Q2 24 | $26.6M | $-25.3M | ||
| Q1 24 | $28.4M | $-36.0M |
| Q4 25 | $27.8M | $35.3M | ||
| Q3 25 | $28.4M | $36.5M | ||
| Q2 25 | $30.4M | $41.3M | ||
| Q1 25 | $33.5M | $28.6M | ||
| Q4 24 | $33.0M | $24.0M | ||
| Q3 24 | $35.9M | $27.5M | ||
| Q2 24 | $32.9M | $32.4M | ||
| Q1 24 | $33.7M | $17.9M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-908.0K | $-2.5M |
| Free Cash FlowOCF − Capex | — | $-2.5M |
| FCF MarginFCF / Revenue | — | -19.1% |
| Capex IntensityCapex / Revenue | 0.0% | 0.3% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-19.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-908.0K | $-2.5M | ||
| Q3 25 | $-533.0K | $-3.7M | ||
| Q2 25 | $-3.3M | $-7.3M | ||
| Q1 25 | $-1.2M | $-4.5M | ||
| Q4 24 | $-770.0K | $-5.7M | ||
| Q3 24 | $-893.0K | $-10.8M | ||
| Q2 24 | $-1.9M | $-13.4M | ||
| Q1 24 | $-658.0K | $-10.9M |
| Q4 25 | — | $-2.5M | ||
| Q3 25 | $-562.0K | $-3.9M | ||
| Q2 25 | $-3.4M | $-7.4M | ||
| Q1 25 | — | $-5.3M | ||
| Q4 24 | $-776.0K | $-5.8M | ||
| Q3 24 | $-940.0K | $-11.0M | ||
| Q2 24 | $-2.0M | $-13.5M | ||
| Q1 24 | — | $-10.9M |
| Q4 25 | — | -19.1% | ||
| Q3 25 | -8.1% | -33.9% | ||
| Q2 25 | -46.8% | -66.1% | ||
| Q1 25 | — | -57.3% | ||
| Q4 24 | -9.7% | -69.7% | ||
| Q3 24 | -11.9% | -149.9% | ||
| Q2 24 | -23.8% | -183.1% | ||
| Q1 24 | — | -169.3% |
| Q4 25 | 0.0% | 0.3% | ||
| Q3 25 | 0.4% | 1.9% | ||
| Q2 25 | 0.7% | 0.8% | ||
| Q1 25 | 0.0% | 8.2% | ||
| Q4 24 | 0.1% | 0.6% | ||
| Q3 24 | 0.6% | 2.3% | ||
| Q2 24 | 0.7% | 0.8% | ||
| Q1 24 | 0.0% | 1.0% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MGLD
| Fund Management Related Party | $4.6M | 60% |
| Food Products | $1.7M | 22% |
| Beauty Products | $1.2M | 15% |
| Other | $268.0K | 4% |
TLSI
Segment breakdown not available.
